Assessing the feasibility, acceptability, and fidelity of a tele-retinopathy-based intervention to encourage greater attendance to diabetic retinopathy screening in immigrants living with diabetes from China and African-Caribbean countries in Ottawa, Canada: a protocol
-
Published:2023-09-09
Issue:1
Volume:9
Page:
-
ISSN:2055-5784
-
Container-title:Pilot and Feasibility Studies
-
language:en
-
Short-container-title:Pilot Feasibility Stud
Author:
Umaefulam Valerie, Wilson Mackenzie, Boucher Marie Carole, Brent Michael H., Dogba Maman Joyce, Drescher Olivia, Grimshaw Jeremy M., Ivers Noah M., Lawrenson John G., Lorencatto Fabiana, Maberley David, McCleary Nicola, McHugh Sheena, Sutakovic Olivera, Thavorn Kednapa, Witteman Holly O., Yu Catherine, Cheng Hao, Han Wei, Hong Yu, Idrissa Balkissa, Leech Tina, Malette Joffré, Mongeon Isabelle, Mugisho Zawadi, Nguebou Marlyse Mbakop, Pabla Sara, Rahman Siffan, Samandoulougou Azaratou, Visram Hasina, You Richard, Zhao Junqiang, Presseau JustinORCID
Abstract
Abstract
Background
Diabetic retinopathy is a leading cause of preventable blindness in Canada. Clinical guidelines recommend annual diabetic retinopathy screening for people living with diabetes to reduce the risk and progression of vision loss. However, many Canadians with diabetes do not attend screening. Screening rates are even lower in immigrants to Canada including people from China, Africa, and the Caribbean, and these groups are also at higher risk of developing diabetes complications. We aim to assess the feasibility, acceptability, and fidelity of a co-developed, linguistically and culturally tailored tele-retinopathy screening intervention for Mandarin-speaking immigrants from China and French-speaking immigrants from African-Caribbean countries living with diabetes in Ottawa, Canada, and identify how many from each population group attend screening during the pilot period.
Methods
We will work with our health system and patient partners to conduct a 6-month feasibility pilot of a tele-retinopathy screening intervention in a Community Health Centre in Ottawa. We anticipate recruiting 50–150 patients and 5–10 health care providers involved in delivering the intervention for the pilot. Acceptability will be assessed via a Theoretical Framework of Acceptability-informed survey with patients and health care providers. To assess feasibility, we will use a Theoretical Domains Framework-informed interview guide and to assess fidelity, and we will use a survey informed by the National Institutes of Health framework from the perspective of health care providers. We will also collect patient demographics (i.e., age, gender, ethnicity, health insurance status, and immigration information), screening outcomes (i.e., patients with retinopathy identified, patients requiring specialist care), patient costs, and other intervention-related variables such as preferred language. Survey data will be descriptively analyzed and qualitative data will undergo content analysis.
Discussion
This feasibility pilot study will capture how many people living with diabetes from each group attend the diabetic retinopathy screening, costs, and implementation processes for the tele-retinopathy screening intervention. The study will indicate the practicability and suitability of the intervention in increasing screening attendance in the target population groups. The study results will inform a patient-randomized trial, provide evidence to conduct an economic evaluation of the intervention, and optimize the community-based intervention.
Publisher
Springer Science and Business Media LLC
Subject
Medicine (miscellaneous)
Reference44 articles.
1. Cruess AF, Gordon KD, Bellan L, Mitchell S, Pezzullo ML. The cost of vision loss in Canada. 2. Results. Can J Ophthalmol J. 2011;46(4):315–8. 2. Boyd SR, Advani A, Altomare F, Stockl F. Retinopathy. Can J Diabetes. 2013;37(Suppl 1):S137–41. 3. Fong DS, Gottlieb J, Ferris FL 3rd, Klein R. Understanding the value of diabetic retinopathy screening. Arch Ophthalmol (Chicago, Ill : 1960). 2001;119(5):758–60. 4. Javitt JC, Aiello LP. Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med. 1996;124(1 Pt 2):164–9. 5. Maberley D, Walker H, Koushik A, Cruess A. Screening for diabetic retinopathy in James Bay, Ontario: a cost-effectiveness analysis. Can Med Assoc J. 2003;168(2):160–4.
|
|